{"id":507744,"date":"2026-06-19T10:13:38","date_gmt":"2026-06-19T10:13:38","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/507744\/"},"modified":"2026-06-19T10:13:38","modified_gmt":"2026-06-19T10:13:38","slug":"some-us-employers-will-drop-glp-1-coverage-starting-in-2027-per-survey","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/507744\/","title":{"rendered":"Some US employers will drop GLP-1 coverage starting in 2027, per survey"},"content":{"rendered":"<p>(<a href=\"https:\/\/www.newsnationnow.com\/\" data-type=\"link\" data-id=\"https:\/\/www.newsnationnow.com\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">NewsNation<\/a>) \u2014 Some U.S. employers say they plan to stop covering <a href=\"https:\/\/www.newsnationnow.com\/health\/experts-warn-of-dosing-issues-with-glp-1-weight-loss-drugs\/\" data-type=\"link\" data-id=\"https:\/\/www.newsnationnow.com\/health\/experts-warn-of-dosing-issues-with-glp-1-weight-loss-drugs\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">GLP-1<\/a> drugs for weight loss next year, according to a recent report.<\/p>\n<p>The report from the <a href=\"https:\/\/www.businessgrouphealth.org\/newsroom\/news-and-press-releases\/press-releases\/2026-glp-1-survey\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Business Group on Health<\/a> surveyed businesses and found that about 10% of employers that currently cover the drugs say they will not continue that coverage by 2027.<\/p>\n<p>\u201cOur findings show the tremendous concern employers have regarding these medications from a cost and financial viability perspective,\u201d Ellen Kelsay, president and CEO of Business Group on Health, said. \u201cAgainst the backdrop of anticipated double-digit health care cost increases \u2014 fueled in large part by GLP-1s and overall prescription drug costs \u2014 companies cannot ignore the reality that GLP-1s have significant implications for health care budgets and overall affordability.\u201d<\/p>\n<p>\t<a href=\"https:\/\/www.newsnationnow.com\/health\/cannabis-sleep-cycle-dependency\/?ipid=promo-link-block1\" class=\"promo-link__link\" target=\"&quot;_blank&quot;\" rel=\"nofollow noopener\"><br \/>\n\t\tUsing cannabis for sleep isn\u2019t harmless \u2013 it can trap people in a cycle of dependency\t<\/a><\/p>\n<p>One company has already made its decision to drop coverage of weight-loss drugs. According to Reuters, health insurer Cigna is <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/some-us-employers-drop-coverage-glp-1-obesity-drugs-2027-use-increases-2026-06-11\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">ending coverage<\/a> of the treatments starting in July and told its employees they could buy them elsewhere.<\/p>\n<p>Weight-loss drugs have become available through some drugmakers\u2019 websites at discounted prices, as well as through a deal with the Trump administration for its <a href=\"https:\/\/www.newsnationnow.com\/health\/trumprx-unveiled-offering-americans-discounted-medications\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">TrumpRx<\/a> site.<\/p>\n<p>Industry experts said demand for the drugs has increased this year due to oral options, attracting people who have never tried GLP-1s and keeping employer costs high.<\/p>\n<p>The Business Group on Health survey also found that about 72% of companies will likely continue to cover weight-loss treatments in 2027.<\/p>\n","protected":false},"excerpt":{"rendered":"(NewsNation) \u2014 Some U.S. employers say they plan to stop covering GLP-1 drugs for weight loss next year,&hellip;\n","protected":false},"author":2,"featured_media":507745,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[3674,103,61,60,371],"class_list":["post-507744","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-author","tag-health","tag-ie","tag-ireland","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/507744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=507744"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/507744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/507745"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=507744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=507744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=507744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}